NCJ Number
237707
Date Published
November 2010
Length
176 pages
Annotation
This report presents information and data on current patterns and trends in the use of amphetamine-type stimulants (ATS) and other drugs in East and Southeast Asia, and it provides overviews for the neighboring regions of South Asia and the Pacific.
Abstract
ATS drugs, particularly methamphetamine (in pill or crystalline form), are widely used in East and Southeast Asia. Between 3.4 million and 20.7 million persons living in the region have used amphetamines in the past year. All 15 countries considered in this report indicate ATS use among their populations. An increasing number of countries have reported the illicit manufacture of ATS. Constituent chemicals needed for the illicit manufacture of ATS are often easily accessible. Data indicate that in East and Southeast Asia, more needs to be done in the development of consolidated responses from the security and health agencies. Despite the increasing number of ATS users in several countries, few treatment facilities are available. Ketamine use and trafficking is also a concern. In 2008, 86 percent of global ketamine seizures occurred in Southeast Asia, heroin seizures in the region increased by approximately 50 percent in 2009. All countries reported cannabis use, and several countries have indicated that the use of inhalants and solvents is a significant problem. The lack of reporting of detailed and consolidated data remains a challenge in many countries in the region, although progress has been made. 105 tables, 40 figures, and numerous references